Peptide record

TPDB06375

Antibacterial Anticancer Antifungal Hemolysis Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06375
Antibacterial Anticancer Antifungal Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab Antifungipept CAFPdb HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 11-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KWLRRVWRWWR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C85H122N28O12
ANDCEQGHIMFPSTY
RW
1728.08
12.88
5
0
6
+5
4.27
-1.591
61.82
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
22000
12.73
0
Residue Composition
number
0
A
4
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
4
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 4 Y: 0 V: 1
Chemical Descriptors
11 reviewed residue count
C85H122N28O12 sequence-only estimate (linear, free termini)
1728.08 sequence-only estimate (linear, free termini)
12.88 sequence-only estimate (linear, free termini)
+5 sequence-only estimate (linear, free termini)
4.27 sequence-only estimate (linear, free termini)
-1.591 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

100% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
100% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Discovery of potent antimicrobial peptide analogs of Ixosin-B. | Bioorg Med Chem Lett | 2012
Evidence 2 Activity

Activity

70.7% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
70.7% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design, Synthesis, and Antimicrobial Activities of Novel Functional Peptides Against Gram-positive and Gram-negative Bacteria. | Chem Biol Drug Des | 2019
Evidence 3 Activity

Activity

71% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
71% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
NOVEL PEPTIDE AND USES THEREOF | Patent US 20160130301 A1 | 2016
Evidence 4 Activity

Activity

% Hemolysis
Toxicity
100 %
Hemolytic
Hemolytic_activity: [Ref.22578463]100% hemolysis at 100µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Bioorg Med Chem Lett. 2012 Jun 15 22(12):4185-8.
Evidence 5 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis